(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Tech Patterns 2023: 12 Advancements to Keep an eye Out For - 2Solid Propensities: Little Changes for a Superior Life
- 3She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'
- 4Exposure to neighborhood violence leads some Denver teens to use tobacco and alcohol earlier, new study shows
- 5Recalled Super Greens diet supplement powder sickens 45 with salmonella
- US EPA will reassess safety of herbicide paraquat, says its chief
- Vote in favor of Your Number one BWM Vehicles
- Boeing's troubled capsule won't carry astronauts on next space station flight
- The most effective method to Safeguard Your Teeth from Acidic Food varieties and Beverages
- Finding the Universe of Computer generated Reality: Individual Encounters
- Courageous Climbing: Trails and Stuff for Outside Lovers
- Flu surges across U.S. as doctor visits reach highest level since 1997
- Want to be better about saving money in 2026? Try these money-saving tips for having a ‘low-buy’ January and beyond
- Manual for 6 well known Amusement Park
